These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26140770)

  • 1. High-Dose Intravenous Octreotide Is Safe and May Be Superior to Surgery in Managing Severe Postesophagectomy Chylothorax in High-Risk Patients.
    Bello SO; Rahamim J
    Ann Thorac Surg; 2015 Jul; 100(1):297-9. PubMed ID: 26140770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Combined Medical Treatment With Etilefrine and Octreotide for Chylothorax After Esophagectomy: A Case Report and Review of the Literature.
    Ohkura Y; Ueno M; Iizuka T; Haruta S; Tanaka T; Udagawa H
    Medicine (Baltimore); 2015 Dec; 94(49):e2214. PubMed ID: 26656358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thoracoscopic management of chylothorax complicating esophagectomy.
    Bonavina L; Saino G; Bona D; Abraham M; Peracchia A
    J Laparoendosc Adv Surg Tech A; 2001 Dec; 11(6):367-9. PubMed ID: 11814127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and predictor of octreotide treatment for postoperative chylothorax after thoracic esophagectomy.
    Fujita T; Daiko H
    World J Surg; 2014 Aug; 38(8):2039-45. PubMed ID: 24705804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful conservative treatment of chylothorax following oesophagectomy - a clinical algorithm.
    Benedix F; Schulz HU; Scheidbach H; Lippert H; Meyer F
    S Afr J Surg; 2010 Jul; 48(3):86-8. PubMed ID: 21924000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of octreotide, a long-acting somatostatin analogue, in the treatment of chylothorax of idiopathic etiology.
    Chen-Scarabelli C; Amà R; Abboud J; Jabarren M; Saravolatz L; Scarabelli TM
    Minerva Chir; 2006 Apr; 61(2):155-8. PubMed ID: 16871146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can octreotide be the first line treatment for chylothorax?
    Leelahanon S; Petlek W; Sontimuang W; Pochanart P; Tepakorn V; Ruangpeg S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S741-5. PubMed ID: 14700175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of octreotide for management of postoperative high-flow chylothorax.
    Barili F; Polvani G; Topkara VK; Dainese L; Roberto M; Aljaber E; Bettoni M; Cheema FH; Trabattuni P; Parolapi A; Spirito R; Biglioli P
    Ann Vasc Surg; 2007 Jan; 21(1):90-2. PubMed ID: 17349344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide use in post-cardiac surgery chylothorax: a 12-year perspective.
    Aljazairi AS; Bhuiyan TA; Alwadai AH; Almehizia RA
    Asian Cardiovasc Thorac Ann; 2017 Jan; 25(1):6-12. PubMed ID: 27920229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postesophagectomy chylothorax: incidence, risk factors, and outcomes.
    Shah RD; Luketich JD; Schuchert MJ; Christie NA; Pennathur A; Landreneau RJ; Nason KS
    Ann Thorac Surg; 2012 Mar; 93(3):897-903; discussion 903-4. PubMed ID: 22245587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of newborn lymphangiectasia and chylothorax after cardiac surgery with octreotide infusion.
    Tibballs J; Soto R; Bharucha T
    Ann Thorac Surg; 2004 Jun; 77(6):2213-5. PubMed ID: 15172310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chylothorax].
    Shiraishi Y
    Kyobu Geka; 2004 Jul; 57(8 Suppl):757-61. PubMed ID: 15362556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful octreotide treatment of chylothorax following coronary artery bypass grafting procedure. A case report and review of the literature.
    Barbetakis N; Xenikakis T; Efstathiou A; Fessatidis I
    Hellenic J Cardiol; 2006; 47(2):118-22. PubMed ID: 16752533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide and chylothorax.
    Kalomenidis I
    Curr Opin Pulm Med; 2006 Jul; 12(4):264-7. PubMed ID: 16825878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chylothorax].
    Migliori C; Boroni G; Milianti S; Ekema G
    Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):89-91. PubMed ID: 21090078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chylothorax complicating esophagectomy for cancer: a plea for early thoracic duct ligation.
    Merigliano S; Molena D; Ruol A; Zaninotto G; Cagol M; Scappin S; Ancona E
    J Thorac Cardiovasc Surg; 2000 Mar; 119(3):453-7. PubMed ID: 10694603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The successful use of octreotide in the treatment of traumatic chylothorax.
    Sharkey AJ; Rao JN
    Tex Heart Inst J; 2012; 39(3):428-30. PubMed ID: 22719161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide for treating chylothorax after cardiac surgery.
    Kilic D; Sahin E; Gulcan O; Bolat B; Turkoz R; Hatipoglu A
    Tex Heart Inst J; 2005; 32(3):437-9. PubMed ID: 16392238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thoracic duct ligation for persistent chylothorax after pediatric cardiothoracic surgery.
    Nath DS; Savla J; Khemani RG; Nussbaum DP; Greene CL; Wells WJ
    Ann Thorac Surg; 2009 Jul; 88(1):246-51; discussion 251-2. PubMed ID: 19559234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of chylothorax with octreotide after congenital heart surgery.
    Tatar T; Kilic D; Ozkan M; Hatipoglu A; Aslamaci S
    Thorac Cardiovasc Surg; 2011 Aug; 59(5):298-301. PubMed ID: 21394709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.